XML 18 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Jun. 30, 2023
Current assets    
Cash and cash equivalents $ 355 $ 367
Receivables, net 679 688
Inventories, net 655 696
Prepaid expenses and other current assets 115 77
Total current assets 1,804 1,828
Property, plant and equipment, net of accumulated depreciation and amortization of $2,792 and $2,705, respectively 1,314 1,345
Operating lease right-of-use assets 354 346
Goodwill 1,252 1,252
Trademarks, net 542 543
Other intangible assets, net 156 169
Other assets 486 462
Total assets 5,908 5,945 Close
Current liabilities    
Notes and loans payable 247 50
Current operating lease liabilities 92 87
Accounts payable and accrued liabilities 1,649 1,659
Income taxes payable 34 121
Total current liabilities 2,022 1,917
Long-term debt 2,479 2,477
Long-term operating lease liabilities 311 310
Other liabilities 852 825
Deferred income taxes 26 28
Total liabilities 5,690 5,557 Close
Commitments and contingencies
Stockholders’ equity    
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of December 31, 2023 and June 30, 2023; and 124,080,634 and 123,820,022 shares outstanding as of December 31, 2023 and June 30, 2023, respectively 131 131
Additional paid-in capital 1,245 1,245
Retained earnings 241 583
Treasury stock, at cost: 6,660,827 and 6,921,439 shares as of December 31, 2023 and June 30, 2023, respectively (1,205) (1,246)
Accumulated other comprehensive net (loss) income (359) (493)
Total Clorox stockholders’ equity 53 220
Noncontrolling interests 165 168
Total stockholders’ equity 218 388 Close
Total liabilities and stockholders’ equity $ 5,908 $ 5,945